Chest CT in patients after lung transplantation: A retrospective analysis to evaluate impact on image quality and radiation dose using spectral filtration tin-filtered imaging.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 17 04 2019
accepted: 14 01 2020
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 1 5 2020
Statut: epublish

Résumé

The purpose of this study was to investigate the impact of a 150kV spectral filtration chest imaging protocol (Sn150kVp) combined with advanced modeled iterative reconstruction (ADMIRE) on radiation dose and image quality in patients after lung-transplantation. This study included 102 patients who had unenhanced chest-CT examinations available on both, a second-generation dual-source CT (DSCT) using standard protocol (100kVp, filtered-back-projection) and, on a third-generation DSCT using Sn150kVp protocol with ADMIRE. Signal-to-noise-ratio (SNR) was measured in 6 standardized regions. A 5-point Likert scale was used to evaluate subjective image quality. Radiation metrics were compared. The mean time interval between the two acquisitions was 1.1±0.7 years. Mean-volume-CT-dose-index, dose-length-product and effective dose were significantly lower for Sn150kVp protocol (2.1±0.5mGy;72.6±16.9mGy*cm;1.3±0.3mSv) compared to 100kVp protocol (6.2±1.8mGy;203.6±55.6mGy*cm;3.7±1.0mSv) (p<0.001), equaling a 65% dose reduction. All studies were considered of diagnostic quality. SNR measured in lung tissue, air inside trachea, vertebral body and air outside the body was significantly higher in 100kVp protocol compared to Sn150kVp protocol (12.5±2.7vs.9.6±1.5;17.4±3.6vs.11.8±1.8;0.7±0.3vs.0.4±0.2;25.2±6.9vs.14.9±3.3;p<0.001). SNR measured in muscle tissue was significantly higher in Sn150kVp protocol (3.2±0.9vs.2.6±1.0;p<0.001). For SNR measured in descending aorta there was a trend towards higher values for Sn150kVp protocol (2.8±0.6 vs. 2.7±0.9;p = 0.3). Overall SNR was significantly higher in 100kVp protocol (5.0±4.0vs.4.0±4.0;p<0.001). On subjective analysis both protocols achieved a median Likert rating of 1 (25th-75th-percentile:1-1;p = 0.122). Interobserver agreement was good (intraclass correlation coefficient = 0.73). Combined use of 150kVp tin-filtered chest CT protocol with ADMIRE allows for significant dose reduction while maintaining highly diagnostic image quality in the follow up after lung transplantation when compared to a standard chest CT protocol using filtered back projection.

Identifiants

pubmed: 32023294
doi: 10.1371/journal.pone.0228376
pii: PONE-D-19-07944
pmc: PMC7001933
doi:

Substances chimiques

Tin 7440-31-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0228376

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur Radiol. 2017 Aug;27(8):3290-3299
pubmed: 28093625
Clin Chest Med. 2011 Jun;32(2):343-55
pubmed: 21511094
Pediatr Radiol. 2017 Jun;47(7):831-837
pubmed: 28352977
Invest Radiol. 2017 Mar;52(3):155-162
pubmed: 27662576
Invest Radiol. 2013 Apr;48(4):206-12
pubmed: 23344517
Eur Radiol. 2011 Mar;21(3):636-43
pubmed: 21080171
Med Phys. 2007 Nov;34(11):4526-44
pubmed: 18072519
Radiology. 2010 Jul;256(1):261-9
pubmed: 20574099
J Biomed Biotechnol. 2012;2012:130169
pubmed: 22619490
Radiology. 2004 May;231(2):440-5
pubmed: 15128988
Eur Radiol. 2015 Jun;25(6):1598-606
pubmed: 25515204
Med Phys. 2011 Mar;38(3):1261-5
pubmed: 21520838
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Eur Radiol. 2011 Mar;21(3):627-35
pubmed: 21053003
Eur Radiol. 2014 Apr;24(4):799-806
pubmed: 24275806
Eur Radiol. 2013 Feb;23(2):360-6
pubmed: 22892722
Med Phys. 2009 Apr;36(4):1359-69
pubmed: 19472643
Acta Radiol. 2011 Dec 1;52(10):1101-6
pubmed: 21903869
AJNR Am J Neuroradiol. 2015 Jul;36(7):1225-30
pubmed: 25814658
Eur J Radiol. 2015 Aug;84(8):1608-1613
pubmed: 26001437
Eur Radiol. 2011 Mar;21(3):510-7
pubmed: 21249371
Chest. 1997 Feb;111(2):370-6
pubmed: 9041984
Invest Radiol. 2014 Jul;49(7):465-73
pubmed: 24598443
Eur Radiol. 2012 Aug;22(8):1613-23
pubmed: 22538629
Eur Radiol. 2016 Sep;26(9):3138-46
pubmed: 26645864
Eur Radiol. 2012 Jan;22(1):138-43
pubmed: 21688003

Auteurs

Alexander Wressnegger (A)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Helmut Prosch (H)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Bernhard Moser (B)

Division of Surgery, Department of Thoracic Surgery, Medical University Vienna, Vienna, Austria.

Walter Klepetko (W)

Division of Surgery, Department of Thoracic Surgery, Medical University Vienna, Vienna, Austria.

Peter Jaksch (P)

Division of Surgery, Department of Thoracic Surgery, Medical University Vienna, Vienna, Austria.

Christopher Lambers (C)

Division of Surgery, Department of Thoracic Surgery, Medical University Vienna, Vienna, Austria.

Konrad Hoetzenecker (K)

Division of Surgery, Department of Thoracic Surgery, Medical University Vienna, Vienna, Austria.

Christian Schestak (C)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Albert De Bettignies (A)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Lucian Beer (L)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Georg Apfaltrer (G)

Division of Pediatric Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.

Helmut Ringl (H)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Paul Apfaltrer (P)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Department of Neuroradiology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH